Stock Research: Dr. Hoenle

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Dr. Hoenle

XTRA:HNL DE0005157101
76
  • Value
    47
  • Growth
    51
  • Safety
    Safety
    72
  • Combined
    67
  • Sentiment
    68
  • 360° View
    360° View
    76
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Dr. Hoenle AG is a Germany-based company specializing in adhesive systems, curing, and disinfection solutions. It operates in the electronics, medical technology, optics, automotive, packaging, surface coatings, furniture, and industrial coating industries. The company operates globally with around 20 subsidiaries. In the last fiscal year, the company had a market cap of $67 million, profits of $65 million, and revenue of $110 million, with 530 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Dr. Hoenle are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Dr. Hoenle. The consolidated Value Rank has an attractive rank of 72, which means that the share price of Dr. Hoenle is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 72% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 68. But the company’s financing is risky with a Safety rank of 47. This means 53% of comparable companies have a safer financing structure than Dr. Hoenle. ...read more

more
Index
CDAX
SDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 70 80 90
Growth
51 39 85 7
Safety
Safety
47 51 41 91
Sentiment
68 76 30 77
360° View
360° View
76 78 75 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 95 97 96
Opinions Change
50 50 6 96
Pro Holdings
n/a 24 1 8
Market Pulse
51 79 40 30
Sentiment
68 76 30 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 70 80 90
Growth
51 39 85 7
Safety Safety
47 51 41 91
Combined
67 61 90 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
35 19 57 92
Price vs. Earnings (P/E)
78 70 57 56
Price vs. Book (P/B)
92 83 80 75
Dividend Yield
41 48 63 86
Value
72 70 80 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
54 58 52 12
Profit Growth
88 87 81 11
Capital Growth
37 7 76 69
Stock Returns
21 32 49 25
Growth
51 39 85 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
39 32 40 48
Refinancing
87 84 69 77
Liquidity
18 29 20 75
Safety Safety
47 51 41 91

Similar Stocks

Discover high‑ranked alternatives to Dr. Hoenle and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Strabag

WBAG:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.